lung metastasis nodules of thyroid cancer
Conditions
Interventions
Sponsors
The First Affiliated Hospital of Soochow University
Eligibility
Sex/Gender
All
Age
18 Years to 76 Years
Inclusion criteria
Inclusion criteria: (1). Patients were diagnosed with differentiated papillary carcinoma of the thyroid, with lung metastasis from thyroid carcinoma confirmed by pathology, serology, and follow-up survey. (2). Patients received 18F-FDG PET/CT examination after surgery. (3). Follow-up time = six months, the serologic and radiomics record of thyroglobulin (Tg), anti-thyroid autoantibodies (TgAb), ultrasonic and diagnostic WBS before and after the treatment were detailed, and the follow-up data is completed.
Exclusion criteria
Exclusion criteria: (1) Patients with the primary lesion are invasive subtypes (including high cell type, island cell type, low differentiation type, diffuse sclerosis type, anamorphic type, or medullary carcinoma) confirmed by pathology. (2) The lung metastasis was not from thyroid carcinoma, confirmed by pathology. (3) Patients that did not receive a serologic examination and Dx-WBS or chest CT 6-12 months after 131I treatment could not be confirmed.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Glucose metabolism level;Sensitivity;Specificity;Accuracy; | — |
Countries
China
Contacts
Public ContactBin Zhang
The First Affiliated Hospital of Soochow University
Outcome results
None listed